Dr. Peter Van Patten trained as a neurologist and is a practicing ophthalmologist and eye surgeon. He holds a B.A. in Environmental Studies, is the founder of Celsprin LLC, and is the inventor of a novel treatment for prophylaxis of migraine using a Cox-2 inhibitor and aspirin (or active derivative). He has practiced ophthalmology including cataract surgery since 1991 and filed his first provisional patent application in August of 2000, leading to an issued patent in March of 2014. He filed his second provisional patent application in December of 2013 and founded Celsprin LLC (an intellectual property holding company) in March of 2014. As a physician board certified in ophthalmology and neurology, he has more than 24 years of clinical and surgical experience and completed two full residency programs as well as a Transitional internship (including rotations in medical and surgical specialties). Dr. Van Patten worked for Kaiser as an emergency room physician on weekends prior to completing his neurology residency. He then worked in the same Department for three months before joining Jackson and Coker as a full time Delaware-based locum tenens neurologist in September of 1987 prior to beginning his ophthalmology residency program in July of 1988. After completing his second residency in 1991, Dr. Van Patten worked in private practice in Central Oregon for two years before becoming an Assistant Professor of Ophthalmology at Southern Illinois University School of Medicine in 1993 (where he served on the Patents and Copyrights Committee). In 1996, Dr. Van Patten joined East Range Clinics as a staff ophthalmologist and was offered shareholder status two years later. After several months, East Range merged with SMDC Health System which subsequently became Essentia Health. In 2006, Dr. Van Patten was invited to become a Board member of the Minnesota Academy of Ophthalmology where he served for six years. He also served as a Board member of the Range Medical Society from 1999 through 2013 and an alternate Delegate and Delegate to the Minnesota Medical Association annual meeting several times, serving on a Reference Committee (including open debate of proposed resolutions) at the Annual Meeting in September of 2011. Dr. Van Patten enjoys fly fishing and other outdoor activities, is a fitness enthusiast, likes to travel, and is also proud to help support his daughter Arabella’s equestrian and educational activities in northern Virginia (where she is a member of the Foxcroft School Equestrian team).
Novel methods and compositions involving Cox-2 inhibition and aspirin (or active derivative)Phacoemulsification, Toric and Multifocal IOLs, Pseudotumor Cerebri, Botox Injection (blepharospasm, hemi-facial spasm).